Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GXCPC1 for Knee Osteoarthritis
NCT03943576Phase 2Completed
- Sponsor
- Gwo Xi Stem Cell Applied Technology Co., Ltd.
- Start
- Dec 2019
- Primary completion
- Apr 2022
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of GXCPC1 in knee osteoarthritis (OA), sponsored by Gwo Xi Stem Cell Applied Technology Co., Ltd.. Started Dec 2019; status: completed.
02
Drugs
GXCPC1
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03943576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03943576.